Experience

• Clean Tech | Renewable Energy

• • Meiji Yasuda Life Insurance Company in its acquisition of Legal and General’s U.S. insurance businesses for $2.28 billion and strategic partnership with Legal and General.
  • Konica Minolta, a Japanese multinational equipment and materials manufacturer operating in the healthcare and industrial industries, in the $600 million sale of its subsidiary, Ambry Genetics, to Tempus AI.
  • Resolution Life, a global life insurance group, in the acquisition of 100% of its shares by Nippon Life Insurance Company at a valuation of $10.6 billion.
  • Konica Minolta, a Japanese multinational equipment and materials manufacturer operating in the healthcare and industrial industries, in the sale of its subsidiary Invicro to Calyx, a portfolio company of CapVest and leading technology-enabled provider.
  • Prudential Financial in the financing aspects of its $7 billion agreement to reinsure a portion of its recently originated Japanese whole life policies with a subsidiary of Prismic Life, a Bermuda-based life and annuity reinsurance company.
  • Sawai and Sumitomo in the $210 million sale of its subsidiary Upsher-Smith Laboratories to Bora Pharmaceuticals.
  • Advantage Partners in a subscription facility with Sumitomo Mitsui Banking Corporation.
  • A Japanese pharmaceutical company in a potential ICC arbitration against a U.S.-based pharmaceutical company arising out of a breach of two collaboration agreements.
  • Mitsui in the formation of the Blue Water Alliance, a joint venture in partnership with Olin Corporation.
  • Toyota Motor Corp. in a resolution with the Department of Justice and Environmental Protection Agency regarding its emissions reporting practices, without any criminal charges being filed.
  • A global private equity fund in its proposed acquisition of Nexon, a Tokyo-listed online video game publisher company in South Korea.
  • KKR and Global Atlantic Financial Group in their strategic partnership with Japan Post Insurance.
  • Mitsui in its agreement to tender its minority stake in Thorne to L Catterton in a take-private transaction with an aggregate value of approximately $680 million.
  • Global biopharmaceutical company in a contractual dispute with a commercial counterparty in a major Asian market.
  • Advantage Partners in the formation of its inaugural Asia Fund investing in small to mid-cap companies across Asia, with total commitments of $380 million.
  • Toyota Motor Corporation in its $394 million investment in Joby Aviation, an aerospace company that is developing and commercializing all-electric vertical takeoff and landing aircraft to enable the deployment of fast, quiet and affordable air taxi services.
  • Carlyle in the formation of Carlyle Asia Growth Partners IV, a $1 billion Asia growth capital fund.
  • Toyota Motor Corporation in its strategic investment in Getaround, a leading carsharing platform.
  • American Airlines in first-ever JOLCO to a U.S. airline involving Crédit Agricole Corporate and Investment Bank, Tokyo Branch, a transaction awarded the “Jolco Finance Deal of the Year: Americas” by Global Transport Finance for its “pioneering Jolco structure”.
  • Toyota Motor Corporation, as an investor in Uber Technologies' self driving unit Advanced Technologies Group (Uber ATG), in its sale of Uber ATG to Aurora.
  • Wilsonart, a Clayton, Dubilier & Rice portfolio company, in the $150 million sale of its Asia Business to Aica Kogyo and the Development Bank of Japan.
  • Toyota Motor Corporation in its joint investment, with DENSO Corporation and SoftBank Vision Fund, in Uber’s Advanced Technologies Group.
  • Toyota Motor Corporation in its $500 million investment in Uber to jointly develop Uber’s self-driving business.
  • Morgan Stanley in the secondary offering and sale of 1,739,071 shares of RenaissanceRe Holdings common stock by Tokio Marine Holdings to Morgan Stanley off a selling stockholder S-3 shelf.
  • A Japanese manufacturer and seller of semiconductor devices in an ICC arbitration seated in New York and governed by Japanese law concerning a contract to supply liquid crystal displays.
  • A Japanese Manufacturer in U.S. DOJ antitrust second request process in connection with acquisition of direct competitor.
  • Sawai Pharmaceutical in its $1.05 billion acquisition of the generic pharmaceuticals business of Upsher-Smith Laboratories.
  • Toyota in the formation of a captive venture capital fund sponsored by Toyota Research Institute and including TMNA as fund investor.
  • A Japanese pharmaceutical company in winning an ICC arbitration against a U.S.-based pharmaceutical company involving a co-development, licensing and supply agreement.
  • Japan Post Holdings in its purchase of a strategic stake of approximately 7% of outstanding common shares of Aflac.
  • Sawai Pharmaceutical in the sale of a minority stake of its U.S. subsidiary, Upsher-Smith Laboratories, to Japanese trading house Sumitomo.
  • Mitsui in its acquisition of an additional 10% limited partnership interest in Penske Truck Leasing from subsidiaries of GE Capital Global Holdings.
  • American International Group in its sale of its Japan life insurance business to FWD.
  • Showa Denko in the U.S. aspects of its acquisition of SGL GE Holding.
  • StanCorp Financial Group in its $5 billion sale to Meiji Yasuda Life Insurance Company.
  • Mitsui in the sale of Transfreight North America, a wholly-owned subsidiary that provides logistics services primarily to automotive manufacturers, to U.S.-based Penske Logistics.
  • Mitsui in its acquisition of a 20% limited partnership interest in Penske Truck Leasing Co., L.P., a full service truck leasing, truck rental and logistics business that mainly operates in the U.S., from General Electric Capital Corporation.
  • Protective Life in its $5.7 billion merger with a subsidiary of Dai-ichi Life, a life insurance company listed on the Tokyo stock exchange.
  • Mitsui in its joint venture with Codelco to acquire 29.5% of Anglo American Sur.
  • Toyota Motor Sales USA in various state and federal investigations relating to vehicle acceleration issues. These included 29 state attorney general investigations, congressional inquiries, SEC investigations and Department of Justice (DOJ) investigations, all of which settled without any criminal convictions for the company.
  • Toyota in its collaboration with Air Liquide to develop and supply 12 state-of-the-art hydrogen stations in five states in the northeast in connection with Toyota's rollout of new hydrogen fuel cell vehicle, Mirai.
  • Mitsui in its acquisition of a 20% limited partnership interest in Penske Truck Leasing Co., L.P.
  • A major Japanese automotive corporation as claimant in consolidated ICC London arbitration proceedings concerning a multibillion-euro cross-shareholding and arising out of a commercial alliance.
  • A significant Japanese investor in its purchase of an interest in one of Brazil’s largest hydroelectric projects.
  • Hisamitsu Pharmaceutical, a leading transdermal patch manufacturer listed on the Tokyo stock exchange, in its $428 million acquisition of Nasdaq-listed Noven Pharmaceuticals via an all-cash tender offer.
  • Mitsui in establishing a significant joint venture with Celanese to manufacture methanol at Celanese’s plant in Clear Lake, Texas.
  • Dentsu in its various sales of shares in Publicis Groupe to Publicis Groupe, amounting to approximately €1 billion.
  • A Japanese bank in the ongoing TIBOR litigation
  • Mitsui in its investment in VLI, a cargo logistics company.
  • Footprint Power in the sale of Salem Harbor Energy Station Project to Highstar Fund IV and Toyota Tsusho, an EPC Contract with Iberdrola Energy Projects, to build a 700MW state-of-the-art combined-cycle gas electric generating facility and a $730 million construction financing, a transaction awarded the Project Finance International “2015 Power Deal of the Year of the Americas” award.
  • Mitsui in its joint venture with Dow Chemical to construct, own and operate a membrane chlor-alkali facility in Freeport, Texas.
  • Mitsui in its joint venture with The Dow Chemical Company to produce biopolymers made from renewable, sugarcane-derived ethanol in Brazil.
  • A large Japanese investor in a significant investment in the U.S. Marcellus shale gas formation.
  • Evercore, as financial advisor to Tokio Marine, in Tokio Marine's $7.5 billion acquisition of HCC Insurance.
  • Morgan Stanley, as financial advisor to Symetra Financial Corp, in the $3.8 billion sale of Symetra Financial Corp to Sumitomo Life.
  • A sovereign wealth fund in its investment in a real estate development partnership with Goodman Japan Limited.
  • American International Group in the tender offer by Chartis Japan Capital to acquire the remaining shares of Fuji Fire and Marine Insurance Co.
  • Prudential Financial in its $4.8 billion acquisition of Japan-based AIG Star Life Insurance and AIG Edison Life Insurance from American International Group.
  • J.C. Flowers in Shinsei Bank's proposed, later terminated, $5.9 billion merger with Aozora Bank.
  • Sithe Global Power in its sale of a 50% interest in Goreway Station to Chubu and Toyota Tsusho.
  • Prudential Financial in matters relating to The Gibraltar Life Insurance Company, a subsidiary of Prudential Financial, in its acquisition of Yamato Life.
  • ORIX Corporation in its investment as a member of a consortium in the consortium's NT$23.8 billion acquisition of a majority interest in EnTie Bank, a Taiwanese commercial bank.